May 04 9:00 AM 10:00 AM | Morning Coffee Commonwealth Hall |
May 04 9:00 AM 4:00 PM | Short Course Registration Commonwealth Hall |
May 04 10:00 AM 1:00 PM | Morning Short Courses |
May 04 2:00 PM 5:00 PM | Afternoon Short Courses |
May 04 4:00 PM 6:00 PM | Main Conference Registration Commonwealth Hall |
May 05 7:00 AM 8:30 AM | Morning Coffee Harbor Level Lobby Analytical • Bioprocess • Engineering • Expression • Formulation • Oncology • Safety • Therapeutics • Antibodies for Cancer Therapy • Biologics for Autoimmune Diseases • Characterization of Biotherapeutics • Difficult to Express Proteins • Formulation Strategies for Improved Delivery • PK/PD of Multi-Domain Proteins • Phage and Yeast Display • Scaling Up and Down Strategies |
May 05 7:00 AM 8:30 AM | Registration Commonwealth Hall Analytical • Bioprocess • Engineering • Expression • Formulation • Oncology • Safety • Therapeutics • Antibodies for Cancer Therapy • Biologics for Autoimmune Diseases • Characterization of Biotherapeutics • Difficult to Express Proteins • Formulation Strategies for Improved Delivery • PK/PD of Multi-Domain Proteins • Phage and Yeast Display • Scaling Up and Down Strategies |
May 05 8:30 AM 8:40 AM | Chairperson’s Opening Plenary Remarks Amphitheater Analytical • Bioprocess • Engineering • Expression • Oncology • Safety • Therapeutics • Antibodies for Cancer Therapy • Biologics for Autoimmune Diseases • Characterization of Biotherapeutics • Difficult to Express Proteins • PK/PD of Multi-Domain Proteins • Phage and Yeast Display • Scaling Up and Down Strategies Kristi Sarno - Pfenex, Inc. |
May 05 8:30 AM 8:40 AM | Chairperson’s Opening Remarks Beacon Hill Formulation • Formulation Strategies for Improved Delivery Christopher A. Rhodes, Ph.D. - Christopher A. Rhodes & Associates LLC |
May 05 8:40 AM 9:10 AM | KEYNOTE PRESENTATION: The Growing Role of BioTherapeutics Delivery: Opportunities and Challenges Beacon Hill Formulation • Presentation • Formulation Strategies for Improved Delivery Julia Rashba-Step, Ph.D. - Pfizer, Inc. |
Stuart A. Aaronson, M.D. Icahn School of Medicine at Mount Sinai Aron Professor and Founding Chair, Emeritus, Oncological Sciences |
Lee Abberley, Ph.D. GlaxoSmithKline Section Manager, Bioanalysis, DMPK |
Yasmina Abdiche, Ph.D. Rinat-Pfizer Research Fellow |
Gregory P. Adams, Ph.D. Fox Chase Cancer Center Co-Leader, Developmental Therapeutics Program |
Nabil M. Ahmed, M.D., MPH Baylor College of Medicine Associate Professor, Pediatrics Center for Cell and Gene Therapy |
Jeff Allen, Ph.D. Pfenex, Inc. Director, Analytical Biochemistry & Protein Purification |
Luis Álvarez-Vallina, M.D., Ph.D. Aarhus University Associate Professor, BCE Protein Engineering |
Nathan J. Alves, Ph.D. Indiana University School of Medicine, Indiana Post-Doctoral Research Fellow |
John Alvino MedImmune Senior Manager, Global Regulatory CMC |
Lakshmi Amaravadi, Ph.D. Biogen Idec, Inc. Senior Director, Translational Medicine |